Puma Biotechnology
PBYI
133 hedge funds and large institutions have $2.52B invested in Puma Biotechnology in 2015 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 41 increasing their positions, 59 reducing their positions, and 47 closing their positions.
104% more call options, than puts
Call options by funds: $67.1M | Put options by funds: $32.8M
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
11% more capital invested
Capital invested by funds: $2.27B → $2.52B (+$252M)
5.94% more ownership
Funds ownership: 93.32% → 99.26% (+5.9%)
18% less funds holding
Funds holding: 163 → 133 (-30)
31% less repeat investments, than reductions
Existing positions increased: 41 | Existing positions reduced: 59
62% less first-time investments, than exits
New positions opened: 18 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Grantham, Mayo, Van Otterloo & Co (GMO)
Boston,
Massachusetts
|
+$96M |
| 2 |
O
OrbiMed
New York
|
+$81.9M |
| 3 |
Millennium Management
New York
|
+$79.7M |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$30.7M |
| 5 |
Balyasny Asset Management
Chicago,
Illinois
|
+$20.7M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Franklin Resources
San Mateo,
California
|
-$52.3M |
| 2 |
Capital International Investors
Los Angeles,
California
|
-$49M |
| 3 |
T
TOBAM
Paris,
France
|
-$24M |
| 4 |
Westfield Capital Management
Boston,
Massachusetts
|
-$16.7M |
| 5 |
JP Morgan Chase
New York
|
-$14.9M |
PBYI Hedge Fund Activity: Q4 2015 in Review
133 of the 3,824 institutional investors tracked by Wall St. Rank reported a position in Puma Biotechnology (PBYI) for Q4 2015, worth a combined $2.52B — up 11% from $2.27B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of PBYI and 18 opened new positions — a net loss of 29 holders — while 59 trimmed existing stakes and 41 added.
The largest buyer was Grantham, Mayo, Van Otterloo & Co (GMO), adding an estimated $96M. The largest seller was Franklin Resources, cutting an estimated $52.3M.
- 133 institutional investors held Puma Biotechnology (PBYI) as of Q4 2015, down from 163 in Q3 2015.
- Funds reported $2.52B of Puma Biotechnology stock for Q4 2015, up 11% quarter-over-quarter.
- 18 funds opened new Puma Biotechnology positions in Q4 2015 and 47 closed out, a net change of -29 holders.
- The largest Puma Biotechnology buyer in Q4 2015 was Grantham, Mayo, Van Otterloo & Co (GMO), an estimated $96M added.
- The largest Puma Biotechnology seller in Q4 2015 was Franklin Resources, an estimated $52.3M sold.
Based on aggregated 13F filings for Q4 2015.